These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 4405674)
21. [Activity of the sympathetic-adrenal system and blood renin level in adolescents with primary arterial hypertension]. Markov KhM; Nebol'sina LI; Pinelis VG Vrach Delo; 1974 Aug; 0(8):9-13. PubMed ID: 4408477 [No Abstract] [Full Text] [Related]
22. Comments on Point:Counterpoint: The dominant contributor to systemic hypertension: Chronic activation of the sympathetic nervous system vs. Activation of the intrarenal renin-angiotensin system. Rohrwasser A J Appl Physiol (1985); 2010 Dec; 109(6):2007. PubMed ID: 21188818 [No Abstract] [Full Text] [Related]
23. The antihypertensive effect of taurine in DOCA-salt rats. Fujita T; Sato Y J Hypertens Suppl; 1984 Dec; 2(3):S563-5. PubMed ID: 6152784 [TBL] [Abstract][Full Text] [Related]
24. Evaluating sympathetic activity in human hypertension. Mancia G; Grassi G; Parati G; Daffonchio A J Hypertens Suppl; 1993 Dec; 11(5):S13-9. PubMed ID: 8158309 [TBL] [Abstract][Full Text] [Related]
25. Altered plasma leucine-enkephalin concentrations in patients with established hypertension. Kraft K; Kokorsch F; Diehl J; Kolloch R; Stumpe KO Prog Clin Biol Res; 1990; 328():367-70. PubMed ID: 2304957 [No Abstract] [Full Text] [Related]
26. Pharmacological mechanism of angiotensin II receptor antagonists: implications for the treatment of elevated systolic blood pressure. Brooks DP; Ruffolo RR J Hypertens Suppl; 1999 Jun; 17(2):S27-32. PubMed ID: 10465064 [TBL] [Abstract][Full Text] [Related]
27. The importance of sleep blood pressure. Morgan TO Expert Rev Cardiovasc Ther; 2010 Jun; 8(6):803-9. PubMed ID: 20528638 [TBL] [Abstract][Full Text] [Related]
29. [Effects of calcium antagonist, angiotensin-converting enzyme inhibitors and beta-blocker on hemodynamic and sympathetic nerve responses to exercise in essential hypertension]. Fujiwara S; Arita M; Ueno Y; Shiotani M; Nakatsu C; Nakamura Y; Hano T; Nishio I; Masuyama Y J Cardiol; 1991; 21(1):115-24. PubMed ID: 1687786 [TBL] [Abstract][Full Text] [Related]
30. Effect of antihypertensive therapy on sympathetic nervous system activity in patients with essential hypertension. Chernow B; Zaloga GP; Lake CR; Coleman MD; Ziegler MG Fed Proc; 1984 Jan; 43(1):72-7. PubMed ID: 6317467 [TBL] [Abstract][Full Text] [Related]
31. Hypertension and associated metabolic abnormalities--the role of insulin resistance and the sympathoadrenal system. Reaven GM; Lithell H; Landsberg L N Engl J Med; 1996 Feb; 334(6):374-81. PubMed ID: 8538710 [No Abstract] [Full Text] [Related]
32. Guanethidine and bethanidine in the management of hypertension. Moser M Am Heart J; 1969 Mar; 77(3):423-6. PubMed ID: 4387977 [No Abstract] [Full Text] [Related]
34. Plasma norepinephrine levels in essential hypertension. Louis WJ; Doyle AE; Anavekar S N Engl J Med; 1973 Mar; 288(12):599-601. PubMed ID: 4686986 [No Abstract] [Full Text] [Related]
35. Role of the sympathetic nervous system in human hypertension. Grassi G J Hypertens; 1998 Dec; 16(12 Pt 2):1979-87. PubMed ID: 9886886 [TBL] [Abstract][Full Text] [Related]
36. Refractory Hypertension: A Novel Phenotype of Antihypertensive Treatment Failure. Dudenbostel T; Siddiqui M; Oparil S; Calhoun DA Hypertension; 2016 Jun; 67(6):1085-92. PubMed ID: 27091893 [No Abstract] [Full Text] [Related]